Literature DB >> 33523441

A Structure-Guided Delineation of FOXP3 Regulation Mechanism in IPEX.

Tengyun Ma1, Xiaomin Song2, Ciriaco A Piccirillo3,4, Guoping Deng5, Mark I Greene6.   

Abstract

The FOXP3 transcription factor acts as a master regulator in the development and function of regulatory T cells (Tregs). Insufficient expression or mutation of FOXP3 gene impairs Treg abundancy and function and causes fatal autoimmune lymphoproliferative diseases in mice and humans. The available crystal structures of FOXP3 protein fragments provide insights into understanding details of the FOXP3 work mechanism in Tregs. This chapter consists of four sections. First, we introduce some features of Treg cells indispensable for the establishment of immune tolerance; second, we describe the critical roles of FOXP3 in Treg development and function; third, we summarize the current available crystal structures of FOXP3 functional domains and related pathogenic mutations in autoimmune diseases; finally, we discuss the potential functional and pathological relevance of FOXP3 protein structure modulation, partner interaction, and posttranslation modification based on the clinical significance in IPEX disease. The information presented in this chapter will help to consider therapeutic strategies to enhance FOXP3 activity and Treg function in the settings of autoimmune disease. Targeting Treg suppression based on FOXP3 structure and interactions hold great promises for the therapy of autoimmune diseases.

Entities:  

Keywords:  Crystal structure; FOXP3; IPEX; Posttranslational modifications; Protein interactions; Regulatory T cells

Mesh:

Substances:

Year:  2021        PMID: 33523441     DOI: 10.1007/978-981-15-6407-9_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  101 in total

1.  Impaired T cell receptor signaling in Foxp3+ CD4 T cells.

Authors:  Bryan D Carson; Steven F Ziegler
Journal:  Ann N Y Acad Sci       Date:  2007-03-21       Impact factor: 5.691

2.  Induction of colonic regulatory T cells by indigenous Clostridium species.

Authors:  Koji Atarashi; Takeshi Tanoue; Tatsuichiro Shima; Akemi Imaoka; Tomomi Kuwahara; Yoshika Momose; Genhong Cheng; Sho Yamasaki; Takashi Saito; Yusuke Ohba; Tadatsugu Taniguchi; Kiyoshi Takeda; Shohei Hori; Ivaylo I Ivanov; Yoshinori Umesaki; Kikuji Itoh; Kenya Honda
Journal:  Science       Date:  2010-12-23       Impact factor: 47.728

3.  Suppression by human FOXP3+ regulatory T cells requires FOXP3-TIP60 interactions.

Authors:  Khalid Bin Dhuban; Eva d'Hennezel; Yasuhiro Nagai; Yan Xiao; Steven Shao; Roman Istomine; Fernando Alvarez; Moshe Ben-Shoshan; Hans Ochs; Bruce Mazer; Bin Li; Chiyoko Sekine; Alan Berezov; Wayne Hancock; Troy R Torgerson; Mark I Greene; Ciriaco A Piccirillo
Journal:  Sci Immunol       Date:  2017-06-16

4.  Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells.

Authors:  Hozefa S Bandukwala; Yongqing Wu; Markus Feuerer; Yongheng Chen; Bianca Barboza; Srimoyee Ghosh; James C Stroud; Christophe Benoist; Diane Mathis; Anjana Rao; Lin Chen
Journal:  Immunity       Date:  2011-03-31       Impact factor: 31.745

5.  No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.

Authors:  Todd Brusko; Clive Wasserfall; Kieran McGrail; Richard Schatz; Hilla Lee Viener; Desmond Schatz; Michael Haller; Jennifer Rockell; Peter Gottlieb; Michael Clare-Salzler; Mark Atkinson
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

6.  Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.

Authors:  Todd M Brusko; Clive H Wasserfall; Michael J Clare-Salzler; Desmond A Schatz; Mark A Atkinson
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

7.  Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

Authors:  Jeffrey A Bluestone; Jane H Buckner; Mark Fitch; Stephen E Gitelman; Shipra Gupta; Marc K Hellerstein; Kevan C Herold; Angela Lares; Michael R Lee; Kelvin Li; Weihong Liu; S Alice Long; Lisa M Masiello; Vinh Nguyen; Amy L Putnam; Mary Rieck; Peter H Sayre; Qizhi Tang
Journal:  Sci Transl Med       Date:  2015-11-25       Impact factor: 17.956

8.  Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.

Authors:  Matthew L Bettini; Fan Pan; Maria Bettini; David Finkelstein; Jerold E Rehg; Stefan Floess; Bryan D Bell; Steven F Ziegler; Jochen Huehn; Drew M Pardoll; Dario A A Vignali
Journal:  Immunity       Date:  2012-05-10       Impact factor: 31.745

9.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

10.  Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Associated With a Novel Mutation of FOXP3 Gene.

Authors:  Charalampos Agakidis; Eleni Agakidou; Kosmas Sarafidis; Ioannis Papoulidis; Ioannis Xinias; Evangelia Farmaki
Journal:  Front Pediatr       Date:  2019-02-05       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.